InvestorsHub Logo
Followers 22
Posts 3477
Boards Moderated 0
Alias Born 02/06/2019

Re: Street Smart post# 8970

Thursday, 06/10/2021 4:33:10 PM

Thursday, June 10, 2021 4:33:10 PM

Post# of 9238
Here is an update on Willow
Willow Biosciences poised to be the first company to commercially produce CBG, the "mother of all cannabinoids"
https://www.proactiveinvestors.com/companies/news/930277/willow-biosciences-poised-to-be-the-first-company-to-commercially-produce-cbg-the--mother-of-all-cannabinoids--930277.html


here is some up to date info from their message board

Outlook

Willow completed its first commercial scale fermentation run of its first cannabinoid, CBG, in Q1 2021 with first sales expected to occur in Q2 2021. While the product volumes are expected to be small to start, this is a significant turning point in the lifecycle of the Company. During the remainder of 2021, Willow plans to optimize its commercial process for CBG, supply product to customers, seed commercial samples to larger organizations, and build out a robust order book for 2022, which the Company expects to be its first full year of commercial production and sales. CBG is a rare cannabinoid and thus Willow is at the forefront of developing that market.


JUST ANNOUNCED

Willow Biosciences and Cellular Goods Announce Multiyear Supply Agreement for Cannabigerol (CBG)
BY CANADA NEWSWIRE — 19 MINUTES AGO
VANCOUVER, BC, June 10, 2021 /CNW/ - Willow Biosciences Inc. ("Willow" or the "Company") , a biotechnology company producing ultra-pure, sustainably made compounds, and Cellular Goods PLC ("Cellular Goods") , a U.K. based provider of premium consumer products based on biosynthetically made cannabinoids, are announcing today that the two companies have signed a multi-year supply agreement, whereby Willow will supply Cellular

Posts are in my opinion. My research could be flawed but I put a strong effort into it

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRON News